LANTERN PHARMA (NASDAQ: LTRN) ESTABLISHES OPEN-MEDICINE AI AS A SEPARATE COMPANY TO COMMERCIALIZE AND EXPAND ITS MULTI-AGENT AI CO-SCIENTIST PLATFORM FOR THE TRANSFORMATION OF MEDICINE

Reuters · 3d ago

Please log in to view news